The government now counts more than 700 reports of serious side effects among Heparin users, and perhaps as many as 21 deaths. A leading American maker, Baxter International Inc., has recalled virtually all of its Heparin products in the United States, and companies in Germany and Japan have recalled their Heparin products.
Other Big Pharma companies have got to be reviewing their off-shore productions facilities, especially those in the PRC:
“I don’t think the pharmaceutical industry knows what it’s doing in China, and I don’t think the U.S. government knows what it’s doing in China,” said Michael Santoro, a Rutgers University business professor who has written about the drug industry’s business in China. He said the Baxter recalls show the need for serious restrictions on Chinese drug imports.